International journal of cancer
Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
Wen-Jiang Yang
Published: 202510.1002/ijc.70288
No abstract available for this study.